Again, human data is insufficient, and anyone considering BPC-157 for this purpose should speak with a knowledgeable medical professional
The FDA label carries warnings about primary pulmonary hypertension and valvular heart disease, though these are rare
Product formulation matters as much as concentration for sensitive skin
Recalls & Warnings March 05, 2021 FTC Takes Further Action Against Deceptive CBD Claims On March 5, 2021, the Federal Trade Commission (FTC) announced that it has approved final administrative consent orders against six companies for selling CBD products with unsupported and deceptive health claims that they can treat a variety of conditions, including cancer, heart disease,
Ye QN, Zhao CQ, Ping J, Xu LM (2021) Study on mechanism of salidroside against liver fibrosis by regulating CXCL16